These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38322287)

  • 41. Oncologic and survival outcomes in elderly patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy and total mesorectal excision.
    He F; Chen M; Xiao WW; Zhang Q; Liu Y; Zheng J; Wan XB; Gao YH
    Jpn J Clin Oncol; 2021 Aug; 51(9):1391-1399. PubMed ID: 34155513
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
    Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
    [No Abstract]   [Full Text] [Related]  

  • 43. Oligometastatic Rectal Adenocarcinoma Treated With Short-Course Radiation Therapy and Chemotherapy With Nonoperative Intent of the Primary for Locoregional Complete Responders.
    Schiff JP; Chin RI; Roy A; Mahapatra L; Stowe HB; Andruska N; Huang Y; Mutch M; Fields RC; Hawkins WG; Doyle M; Chapman W; Tan B; Henke LE; Badiyan SN; DeSelm C; Samson PP; Pedersen K; Kim H
    Pract Radiat Oncol; 2022; 12(5):e406-e414. PubMed ID: 35526826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of adjuvant chemotherapy in rectal cancer patients with ypT0-2N0 after neoadjuvant chemoradiotherapy.
    Yang J; Deng Q; Chen Z; Chen Y; Fu Z
    Front Oncol; 2024; 14():1338098. PubMed ID: 38406812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced rectal adenocarcinoma.
    Shamseddine A; Zeidan YH; Kreidieh M; Khalifeh I; Turfa R; Kattan J; Mukherji D; Temraz S; Alqasem K; Amarin R; Al Awabdeh T; Deeba S; Jamali F; Mohamad I; Elkhaldi M; Daoud F; Al Masri M; Dabous A; Hushki A; Jaber O; Khoury C; El Husseini Z; Charafeddine M; Al Darazi M; Geara F
    BMC Cancer; 2020 Sep; 20(1):831. PubMed ID: 32873251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
    Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
    Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial.
    Fokas E; Schlenska-Lange A; Polat B; Klautke G; Grabenbauer GG; Fietkau R; Kuhnt T; Staib L; Brunner T; Grosu AL; Kirste S; Jacobasch L; Allgäuer M; Flentje M; Germer CT; Grützmann R; Hildebrandt G; Schwarzbach M; Bechstein WO; Sülberg H; Friede T; Gaedcke J; Ghadimi M; Hofheinz RD; Rödel C;
    JAMA Oncol; 2022 Jan; 8(1):e215445. PubMed ID: 34792531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-course Versus Long-course Preoperative Radiotherapy plus Delayed Surgery in the Treatment of Rectal Cancer: a Meta-analysis.
    Liu SX; Zhou ZR; Chen LX; Yang YJ; Hu ZD; Zhang TS
    Asian Pac J Cancer Prev; 2015; 16(14):5755-62. PubMed ID: 26320447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preoperative short-course radiation therapy for rectal cancer provides excellent disease control and toxicity: Results from a single US institution.
    Roy A; Mahasittiwat P; Weiner AA; Hunt SR; Mutch MG; Birnbaum EH; Kodner IJ; Read TE; Fleshman JW; Olsen JR; Myerson RJ; Parikh PJ
    Pract Radiat Oncol; 2017; 7(1):e51-e58. PubMed ID: 27720702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinicopathological Outcomes in Patients With Locally Advanced Rectal Cancer Undergoing Preoperative Short-
    Kim JS; Chung MJ; Lee DY; Lee SH; Jeong SK; Yoo BE; Chung CS; Chung WK
    In Vivo; 2023; 37(6):2768-2775. PubMed ID: 37905618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pragmatic use of short-course radiotherapy, chemotherapy and surgery for stage IV rectal cancer with locally advanced or symptomatic primary tumours.
    Higgins MJ; Mulsow J; Staunton O; Aird J; Cronin C; Dunne MT; Burke J; Shields C; Faul E; McCawley N; Toomey D; Conneely J; O'Neill B
    J Med Imaging Radiat Oncol; 2021 Dec; 65(7):940-950. PubMed ID: 34464496
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Personalized total neoadjuvant therapy versus chemotherapy during the 'wait period' versus standard chemoradiotherapy for locally advanced rectal cancer.
    Bedrikovetski S; Traeger L; Fitzsimmons T; Perry J; Vather R; Moore JW; Sammour T
    ANZ J Surg; 2023 May; 93(5):1267-1273. PubMed ID: 36573638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Organ preservation following short-course radiotherapy for rectal cancer.
    Nilsson PJ; Ahlberg M; Kordnejad S; Holm T; Martling A
    BJS Open; 2021 Sep; 5(5):. PubMed ID: 34686879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MRI demonstration of the effect of neoadjuvant radiotherapy on rectal carcinoma.
    Jacques AE; Rockall AG; Alijani M; Hughes J; Babar S; Aleong JA; Cottrill C; Dorudi S; Reznek RH
    Acta Oncol; 2007; 46(7):989-95. PubMed ID: 17851843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 56. Selecting a TNT Schedule in Locally Advanced Rectal Cancer: Can We Predict Who Actually Benefits?
    Aschele C; Glynne-Jones R
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174033
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health Service.
    Morris EJA; Finan PJ; Spencer K; Geh I; Crellin A; Quirke P; Thomas JD; Lawton S; Adams R; Sebag-Montefiore D
    Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):522-531. PubMed ID: 26936609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stepwise neoadjuvant chemoradiotherapy in the management of mid-low locally advanced rectal cancer.
    Zhang YX; Liu HY; Jiang B; Wang WY; Wang HB; Lu YJ
    Eur J Surg Oncol; 2020 Mar; 46(3):410-414. PubMed ID: 31627933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oncologic outcomes of neoadjuvant chemoradiation for locally advanced rectal cancer: a single-institution experience.
    Leong YH; Leong CN; Tay GS; Sim R; Lopes G; Low W; Choo BA; Tey J
    Ann Acad Med Singap; 2014 Dec; 43(12):569-75. PubMed ID: 25588915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival.
    Theodoropoulos G; Wise WE; Padmanabhan A; Kerner BA; Taylor CW; Aguilar PS; Khanduja KS
    Dis Colon Rectum; 2002 Jul; 45(7):895-903. PubMed ID: 12130878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.